General Remarks 1 H and 13 C NMR spectra were recorded with Bruker DPX-400, AVANCE-400 and DRX-500. The numbering of the protons relate to the numbering chosen in Fig. 1 . High resolution mass spectra were obtained with a Micromass LCT via loop-mode injection from a Waters (Alliance 2695) HPLC system. Alternatively a Micromass Q-TOF in combination with a Waters Aquity Ultraperformance LC system was employed. Ionization was achieved by ESI or APCI. Modes of ionization, calculated and found mass are given. RP -HPLC was performed on RP-CN with CH 3 CN/H 2 O gradient eluation. CD spectra were obtained using a Jasco J-810 circular dichroism spectropolarimeter. Analytical thin-layer chromatography was performed using precoated silica gel 60 F 254 plates (Merck, Darmstadt). Flash column chromatography was performed on Merck silica gel (230-400 mesh). Unless otherwise noted, all reactions were carried out under an atmosphere of nitrogen in dry glassware. Commercially available reagents and dry solvents were used as received.
, found: 680.3016 [M+Na] + .
(2S,3R)-3-(4-methoxybenzyloxy)-2-methylpentan-1-ole (S1):
To a solution of PMB-ether 6 (9.7 g, 14.7 mmol, 1.0 eq) in THF (100 mL) was added DIBAL-H (1.0 mol/L in hexane, 44 mL, 44.0 mmol, 3.0 eq) at -78 °C. After 1 h, the reaction was warmed up to -20 °C. After 2 h a sat. aq. solution of Rochelle's salt was added and the mixture was stirred 30 min at room temperature. After extraction with CH 2 Cl 2 the combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 5:1) furnished alcohol S1 as colorless oil (3.2 g, 13.4 mmol, 91%).
[α] 20 = 77.0 ppm) δ 159.2 (q, PMB), 130.3 (q, PMB), 129.4 (2x t, PMB), 113.9 (2x t, PMB), 84.7 (t, C-20) , 71.2 (s, PMB), 67.0 (s, C-18), 55.2 (p, PMB), 37.1 (t, C-19), 23.0 (s, C-21), 14.1 (t, C-23), 8.3 (p, C-22) 
(2S,3R)-3-(4-methoxybenzyloxy)-2-methylpentanal (S2):
To a solution of carbinol S1 (1.6 g, 6.5 mmol, 1.0 eq) in CH 2 Cl 2 (120 mL) were sequentially added NaHCO 3 (2.7 g, 32.5 mmol, 5.0 eq) and DESS-MARTIN periodinane (4.1 g, 9.8 mmol, 1.5 eq) at room temperature. After 30 min, the reaction was terminated by addition of a sat. aq. Na 2 S 2 O 3 solution and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The crude aldehyde S2 was used in the next step without further purification.
(3S,4R,5R)-3-(tert-butyldimethylsilyloxy)-1-[(R)-4-isopropyl-2-thioxothiazolidin-3-yl]-5-(4-methoxybenzyloxy)-4-methylheptan-1-one (S3):
TiCl 4 (1.3 mL, 11.7 mmol, 1.8 eq) was added to a solution of 1-[(R)-4-isopropyl-2-thioxothiazolidin-3-yl]ethanone (11) 6 (2.3 g, 11.1 mmol, 1.7 eq) in CH 2 Cl 2 (250 mL) at -50 °C. After stirring for 20 min DIPEA (1.9 mL, 11.7 mmol, 1.8 eq) was added to the reaction mixture. After stirring for 2 h at -40 °C the reaction mixture was cooled to -78 °C and aldehyde S2 (1.5 g, 6.5 mmol, 1.0 eq) in CH 2 Cl 2 (80 mL) was added. After 2 h the reaction mixture was terminated by addition of a sat. aq. NH 4 Cl solution and was warmed up to room temperature. The aqueous layer was extracted with CH 2 Cl 2 and the combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure to furnish the crude product as an orange oil.
This material was dissolved in CH 2 Cl 2 (250 mL) and 2,6-lutidine (1.3 mL, 11.4 mmol, 1.8 eq) as well as TBSOTf (2.1 mL, 9.1 mmol, 1.4 eq) were sequentially added at -78 °C. The mixture was warmed to room temperature and stirred for 3 h. The reaction was terminated by addition of a sat. aq. NH 4 Cl solution and extracted with CH 2 Cl 2 . The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 15:1) yields the TBS-PMB-ether S3 as a yellow oil (3.5 g, 6.3 mmol, 97%). (ddd, J = 7.7, 6.6, 3.9 Hz, 1H, , 3.01 (dd, J = 11.4, 0.7 Hz, 1H, SCH 2 ), 2.97 (dd, J = 17.1, 2.2 Hz, 1H, H-17'), 2.40 [psext, J = 6.6 Hz, 1H, CH(CH 3 ) 2 ], 1.95 (ddq, J = 14.6, 6.6, 3.8 Hz, 1H, H-19), 1.70 (ddq, J = 14.6, 14.2, 3.9 Hz, 1H, H-21), 1.49 (ddq, J = 14.2, 7.7, 7.1 Hz, 1H, H-21'), 1.06 [d, J = 6.6 
(3S,4R,5R)-3-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)-4-methylheptanoic acid (7):
To a solution of S3 (198 mg, 0.4 mmol, 1.0 eq) in THF/H 2 O (4:1, 8.3 mL) were sequentially added H 2 O 2 (30%, 88 µL, 2.9 mmol, 8.0 eq) and 1 N aqueous LiOH (1.4 mL, c = 1 mol/L, 1.4 mmol, 4.0 eq) at 0 °C and the reaction mixture was allowed to warm to room temperature. After 3 h, the reaction was terminated by addition of a sat. aq. Na 2 S 2 O 3 solution and H 2 O and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 5:1) furnished carboxylic acid 7 as a colorless oil (132 mg, 0.5 mmol, 90%).
[α] (ddd, J = 7.5, 4.6, 4.2 Hz, 1H, , 2.46 (dd, J = 15.0, 4.2 Hz, 1H, H-17), 2.39 (dd, J = 15.0, 7.9 Hz, 1H, H-17'), 1.98 (ddq, J = 7.9, 7.3, 4.2 1H, 1.69 (pdddd, J = 14.7, 14.5, 7.3, 4.6 Hz, 1H, 1.49 (pdddd, J = 14.5, 13.2, 7.5, 7.3 Hz, 1H, 0.93 (t, J = 7.3 Hz, 3H, 
(R)-Methyl-2-[(3S,4R,5R)-3-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)-4-methylheptanamido]-3-hydroxypropanoate (S4):
To a solution of TBTU (103 mg, 0.3 mmol, 1.0 eq) and HOBt (49 mg, 0.3 mmol, 1.0 eq) in CH 2 Cl 2 (2 mL) were sequentially added acid 7 (132 mg, 0.3 mmol, 1.0 eq) in CH 2 Cl 2 (2 mL) and DIPEA (0.2 mL, 1.0 mmol, 3.0 eq). After stirring for 2 h at room temperature L-serine methyl ester (12) (60 mg, 0.4 mmol, 1.2 eq) was added to the reaction mixture and stirring was continued for 3 d at room temperature. (ddd, J = 7.3, 3.9, 3.8 Hz, 1H, , 4.43 (d, J = 10.9 Hz, 1H, PMB), 4.41 (d, J = 10.9 Hz, 1H, PMB), 4.20 (q, J = 5.9 Hz, 1H, H-18), 3.89 (dd, J = 11.0, 3.9 Hz, 1H, H-15), 3.81 (dd, J = 11.0, 3.8 Hz, 1H, H-15'), 3.79 (s, 3H, PMB), 3.74 (s, 3H, CH 3 O), 3.42 (ddd, J = 6.9, 6.7, 3.6 Hz, 1H, 2.55 (dd, J = 14.3, 5.9 Hz, 1H, , 2.47 (bs, 1H, OH), 2.34 (dd, J = 14.3, 5.9 Hz, 1H, H-17'), 2.13 (pdddd, J = 12.4, 6.7, 6.7, 5.9 Hz, 1H, 1.62 (ddddd, J = 14.4, 7.7, 7.3, 6.9, 3.6 Hz, 1H, To a solution of S4 (1.7 g, 3.2 mmol, 1.0 eq) in CH 2 Cl 2 (50 mL) was added DAST (0.5 mL, 3.9 mmol, 1.2 eq) at -78 °C. After stirring for 2 h at -78 °C K 2 CO 3 (807 mg, 5.8 mmol, 1.8 eq) and a sat. aq. K 2 CO 3 solution were added and the reaction mixture was allowed to warm up to room temperature. After extraction with CH 2 Cl 2 , the combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl amine = 4:1) furnished oxazolidine S5 as a colorless oil (1.3 g, 2.7 mmol, 82%). 
Methyl-2-[(2S,3R,4R)-2-(tert-butyldimethylsilyloxy)-4-(methoxybenzyloxy)-3-methylhexyl]oxazol-4-carboxylate (8):
To a suspension of anhydrous CuBr 2 (0.9 g, 4.1 mmol, 4.0 eq) in CH 2 Cl 2 (15 mL) were added HMTA (0.6 g, 4.1 mmol, 4.0 eq) and DBU (0.6 mL, 4.1 mmol, 4.0 eq). A solution of S5 (0.5 g, 1.0 mmol, 1.0 eq) in CH 2 Cl 2 (15 mL) was added to the suspension and the reaction mixture was stirred for 2 h at room temperature. The organic solvent was removed under reduced pressure and ethyl acetate and a solution of sat. aq. NH 4 Cl/30%-NH 3 (1:1, 100 mL) were sequentially added to the oily residue. The aqueous layer was extracted with ethyl acetate and the combined organic extracts were sequentially washed with a solution of sat. aq. NH 4 Cl/30%-NH 3 (1:1; 3x), 10%-citric acid, sat. aq. NaHCO 3 and NaCl. The organic extract were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 5:1) furnished oxazole 8 as a colorless oil (0.5 g, 1.0 mmol, quant).
[α] 
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2-[(2S,3R,4R)-2-(tert-butyldimethylsilyloxy)-4-(methoxybenzyloxy)-3-methylhexyl]oxazol-4-carbaldehyde (S6):
To a solution of 8 (250 mg, 1.0 mmol, 1.0 eq) in CH 2 Cl 2 (15 mL) was added Dibal-H (1.2 mol/L in toluene, 3.0 mL, 3.6 mmol, 6.0 eq) at -78 °C within 45 min. After 30 min the reaction was terminated by addition of methanol. A saturated aqueous solution of Rochelle's salt was added and the mixture was stirred at room temperature over night. After extraction with CH 2 Cl 2 , the combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 6:1 → 1:1) furnished aldehyde S6 as a colorless oil (438 mg, 0.9 mmol, 94%). 
2-[(2S,3R,4R)-2-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-3-methylhexyl]-4-ethynyloxazole (S7):
To a solution of S6 (438 mg, 0.9 mmol, 1.0 eq) in MeOH (10 mL) were sequentially added K 2 CO 3 (328 mg, 2.4 mmol, 2.5 eq) and the OHIRA-BESTMANN reagent 13 8 (456 mg, 2.4 mmol, 1.5 eq) at 0 °C. The reaction mixture was allowed to warm to room temperature over night and was terminated by addition of Et 2 O and H 2 O. After extraction with Et 2 O, the combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 6:1) furnished alkine S7 as a colorless oil (376 mg, 0.8 mmol, 84%).
2-{(2S,3R,4R)-2-(tert-butyldimethylsilyloxy)-4-[(4-methoxybenzyl)oxy]-3-methylhexyl}-4-[(E)-2-iodovinyl]oxazole (9):
To a suspension of SCHWARTZ reagent 14 (433 mg, 1.7 mmol, 2.5 eq) in THF (7 mL) was added S7 (308 mg, 0.7 mmol, 1.0 eq) in THF (7 mL) at 0 °C. After 1 h NIS (378 mg, 1.7 mmol, 2.5 eq) in THF (8 mL) was added at -78 °C and the reaction mixture was stirred in the dark for 40 min. The reaction mixture was terminated by addition of a sat. aq. Na 2 S 2 O 3 solution and the aqueous layer was extracted with Et 2 O. The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 12:1) furnished vinyliodide 9 as a colorless oil (348 mg, 0.6 mmol, 88%).
18-TBS-20-PMB-protected noricumazole A 15a and 11-epi-18-TBS-20-PMB-protected noricumazole A 15b:
Method A: To a solution of t-BuLi (1.7 mol/L in pentane, 0.8 mL, 1.4 mmol, 4.1 eq) in degassed Et 2 O (10 mL) was added vinyliodide 9 (388 mg, 0.7 mmol, 2.0 eq) in Et 2 O (8 mL) at -78 °C under an argon atmosphere. After 1 h, dimethylzinc (1.2 mol/L in toluene, 0.6 mL, 0.7 mmol, 2.0 eq) was added at -78 °C and the reaction mixture was stirred for 15 min. Aldehyde 4 (92 mg, 0.3 mmol, 1.0 eq) in Et 2 O (8 mL) was added and stirring was continued at -78 °C for 3 h. 
Method B:
To a solution of nitrobenzoate S8 (2 mg, 2.3 µmol, 1.0 eq) in THF/MeOH (2:1, 0.15 mL) were added NaOH (0.5 mg, 13.6 µmol, 6.0 eq) and H 2 O (0.1 mL) at 0 °C. The reaction mixture was stirred for 16 h. H 2 O was added and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic extracts were dried (MgSO 4 ) and concentrated under reduced pressure. Purification by flash chromatography (PE:EA = 6:1) furnished allylic alcohol 15a as a colorless oil (2 mg, 2.0 µmol, 90%). .1 (q, C-3), 160.5 (q, PMB), 159.0 (q, C-16), 137.6 (q, C-7), 137.2 (t, C-15), 136.5 (q, C-14), 135.1 (t, C-5), 132.6 (t, C-12), 131.0 (q, PMB), 129.3 (2x t, PMB), 128.9 (q, C-4), 119.5 (t, C-13), 117.1 (t, C-6), 113.6 (3x t, PMB), 107.7 (s, C-2), 80.5 (t, C-20), 77.7 (t, C-9), 70.8 (t, C-18), 70.7 (s, PMB), 69.4 (t, C-11), 55.2 (p, PMB), 41.9 (t, C-19), 41.5 (s, C-10), 36.8 (s, C-24), 34.7 (t, C-25), 33.0 (s, C-8), 32.0 (s, C-17), 29.7 (s, C-26), 25.7 (3x p, TBS), 22.9 (s, C-21), 19.0 (t, C-28), 17.8 (q, TBS), 11.5 (p, C-27), 10. 
4-Nitrobenzoate S8:
To a solution of 11-epi-15a (5 mg, 6.8 μmol, 1.0 eq) in THF (2 mL) were sequentially added triphenylphosphine (18 mg, 0.1 mmol, 10.0 eq), 4-nitrobenzoic acid (11 mg, 0.1 mmol, 10.0 eq) and diethyl azodicarboxylate (40% in toluene, 32 µL, 0.1 mmol, 10.0 eq) at 0 °C. The reaction temperature was raised to room temperature and the reaction stirred for 30 min. H 2 O was added and the aqueous layer was extracted with ethyl acetate. The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. Purification by flash chromatography (petroleum ether : ethyl acetate = 6:1 → 4:1) furnished nitrobenzoate S8 as a colorless oil (5 mg, 5.9 μmol, 86%). 3,11-Acetate-18-TBS-20-PMB protected 11-epi-noricumazole A S9a und 11-epi-S9b:
To a solution of alkohol 15a (27 mg, 36.0 µmol, 1.0 eq) in CH 2 Cl 2 (7 mL) was added DMAP (0.9 mg, 7.2 µmol, 0.2 eq), pyridine (13 µL, 158.4 µmol, 4.4 eq) and acidic anhydride (8 µL, 79.2 µmol, 2.2 eq) at room temperature. The reaction was = 13.3, 8.7 Hz, 1H, H-24'), 2.32-2.27 (m, 1H, H-10), 2.29 (s, 3H, Ac), 2.10 (ddd, J = 13.9, 7.2, 4.5 Hz, 1H, H-10'), 2.06 (s, 3H, Ac), 1.98 (ddd, J = 6.6, 4.0, 1.9 Hz, 1H, H-19), 1.82 (pdddd, J = 14.6, 7.3, 7.3, 4.3 Hz, 1H, 1H, 1.50 (pdddd, J = 14.6, 7.3, 7.3, 5 To a solution of protected noricumazole A S9a (14 mg, 17.3 µmol, 1.0 eq) in THF (7 mL) was added hydrofluoric acid in pyridine (70%, as HF 30%, 0.7 mL) via a syringe pump over 14 h at room temperature. The reaction was terminated by addition of sat. aq. NaHCO 3 solution and the aqueous layer was extracted with ethyl acetate. The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The residue was taken up in MeOH and H 2 O (1:1) and purified by RP-HPLC (MeOH:H 2 O, gradient eluation). Compound 16a (8 mg, 11.9 µmol, 69%, 89% b.r.s.m.) was obtained as a colorless oil. As a side product acetate-protected 17a was obtained. .4 Hz, 1H, H-17'), 2.59 (dd, J = 13.3, 6.1 Hz, 1H, H-24), 2.38-2.31 (m, 1H, H-24'), 2.31 (s, 3H, Ac), 2.14 (dd, J = 6.7, 5.8 Hz, 2H, H-10), 2.06 (s, 3H, Ac), 2.02 (sext, J = 6.6 Hz, 1H, H-19), 1.70 (pdddd, J = 7.2, 7.2, 6.6, 3.6 Hz, 1H, H-21), 1.64-1.58 (m, 1H, H-25), 1.47 (sext, J = 7.2 Hz, 1H, H-21'), 1.41-1.30 (m, 1H, H-26), 1.30-1.17 (m, 1H, H-26'), 0.94 (t, J = 7.2 Hz, 3H, H-27), 0.91 (t, J = 8.7 Hz, 3H, H-22), 0.90 (d, J = 7.9 Hz, 3H, H-23), 0.85 (d, J = 6.6 Hz, 3H, H-28) ppm; 13 C-NMR (125 MHz, MeOH d 4 , MeOH d 3 = 49.0 ppm) δ 172.1 (2x q, Ac), 171.2 (q, C-1), 165.7 (q, C-16), 160.8 (q, PMB), 149.7 (q, C-3), 140.6 (q, C-7), 139.0 (q, C-14), 137.8 (t, C-15), 137.7 (t, C-5), 135.5 (q, C-4), 132.1 (q, PMB), 130.8 (2x t, PMB), 129.8 (t, C-12), 126.1 (t, C-6), 122.0 (t, C-13), 118.6 (q, C-2), 114.7 (2x t, PMB), 82.1 (t, C-20), 76.3 (t, C-9), 72.0 (s, PMB), 71.7 (t, C-11), 71.6 (t, C-18), 55.7 (p, PMB), 42.1 (t, C-19), 40.5 (s, C-10), 38.1 (s, C-24), 36.9 (t, C-25), 34.3 (s, C-8 = 7.8 Hz, 1H, 6.54 (dd, J = 15.8, 0.6 Hz, 1H, 6.32 (dd, J = 15.8, 6.5 Hz, 1H, 5.65 (q, J = 6.5 Hz, 1H, 1H, 4.18 (ddd, J = 9.5, 6.7, 3.3 Hz, 1H, 3.54 (ddd, J = 9.0, 6.7, 2.6 Hz, 1H, 1H, 3.00 (dd, J = 16.4, 3.9 Hz, 1H, 3.00 (dd, J = 15.1, 3.3 Hz, 1H, 2.81 (dd, J = 15.1, 9.5 Hz, 1H, 2.59 (dd, J = 13.4, 6.1 Hz, 1H, 1H, , 2.32 (s, 3H, Ac), 2.15 (pt, J = 6.5 Hz, 2H, H-10), 2.07 (s, 3H, Ac), 1.77 (sext, J = 6.7 Hz, 1H, 2H, 2H, J = 7.2 Hz, 1H, 0.98 (t, J = 7.4 Hz, 3H, 0.92 (t, J = 7.5 Hz, 3H, 0.91 (d, J = 7.0 Hz, 3H, 0.85 (d, J = 6.6 Hz, 3H, ppm; 13 C-NMR (125 MHz, MeOH d 4 , MeOH d 3 = 49.0 ppm) δ 172.1 (2x q, Ac), 171.2 (q, C-1), 165.9 (q, C-16), 149.6 (q, C-3), 140.7 (q, C-7), 138.9 (t, C-5), 137.8 (t, C-15), 130.7 (q, C-14) , 129.8 (t, C-12), 126.1 (t, C-6), 122.0 (t, C-13), 118.5 (q, C-4), 114.8 (q, C-2), 76.3 (t, C-9), 75.4 (t, C-20), 72.3 (t, C-18), 71.6 (t, C-11), 45.6 (t, C-19) , 40.5 (s, C-10), 38.1 (s, C-24), 36.9 (t, C-25), 34.3 (s, C-8), 33.7 (s, C-17), 30.5 (s, C-26), 27.2 (s, C-21), 21.1 (p, Ac), 21.0 (p, Ac), 19.4 (t, C-28), 11.9 (p, C-23), 11.3 (p, C-22), 10.4 (p, C-27) (s, 1H, 7.49 (d, J = 7.8 Hz, 1H, 7.19 (d, J = 7.8 Hz, 1H, 6.55 (dd, J = 15.6, 0.2 Hz, 1H, 6.31 (dd, J = 15.6, 7.1 Hz, 1H, 5.66 (ddd, J = 7.1, 6.9, 6.9 Hz, 1H, 4.58 (ddd, J = 7.1, 6.9, 6.9 Hz, 1H, 4.17 (dddd, J = 10.5, 8.1, 3.9, 3.6 Hz, 1H, 3.53 (ddd, J = 8.9, 6.6, 2.7 Hz, 1H, 3.06 (dd, J = 16.0, 3.6 Hz, 1H, 3.04 (dd, J = 16.0, 3.9 Hz, 1H, 3.00 (dd, J = 15.0, 3.2 Hz, 1H, 2.80 (dd, J = 15.0, 9.6 Hz, 1H, 2.58 (dd, J = 13.4, 6.1 Hz, 1H, 1H, 2.31 (s, 3H, Ac), 2.28 (ddd, J = 14.4, 8.1, 6 .9 Hz, 1H, H-10), 2.11-2.06 (m, 1H, H-10'), 2.08 (s, 3H, Ac), 1.76 (sext, J = 6.6 Hz, 1H, 2H, A solution of acceptor 16a (8 mg, 11.9 µmol, 1.0 eq) in CH 2 Cl 2 (2.3 mL) was added to activated molecular sieves (powder, 4Å) under an atmosphere of argon. Hg(CN) 2 (7 mg, 26.1 µmol, 2.2 eq) was added to the suspension at room temperature. After stirring for 45 min glycosyl donor 18 (45 mg, 85.6 µmol, 7.2 eq) in CH 2 Cl 2 (1.5 mL) which was codistilled before with benzene was added. After 2.25 h the reaction was quenched by addition of MeOH. The reaction mixture was filtered over Celite ® and the organic layer washed with a sat. aq. KBr solution and water. The organic extract was dried over MgSO 4 and concentrated under reduced pressure. The residue was taken up in MeOH and H 2 O (1:1) and purified by RP-HPLC (MeOH:H 2 O, gradient eluation). Aglycon S10 (6 mg, 5.2 µmol, 47%) was obtained as a colorless oil. .6 (q, Bz), 167.1 (q, Bz), 166.5 (q, Bz), 164.7 (q, C-16), 160.7 (q, PMB), 149.0 (q, C-3), 140.6 (t, C-7), 139.1 (t, C-15), 137.8 (q, C-5), 134.9 (q, C-14), 130.91 (q, PMB), 130.9 (3x t, Bz), 130.89 (2x t, PMB), 130.8 (2x t, Bz), 129.9 (2x t, Bz), 129.86 (t, C-12), 129.8 (q, C-4), 129.77 (3x t, Bz), 128.9 (t, C-5), 127.0 (t, C-6), 121.8 (t, C-13), 118.5 (q, C-2), 114.7 (2x t, PMB), 107.4 (t, C-1'), 83.3 (t, C-4'), 83.1 (t, C-2'), 81.2 (t, C-20), 79.2 (t, C-3'), 79.1 (t, C-18), 76.1 (t, C-9), 71.6 (s, PMB), 71.4 (t, C-11), 65.0 (s, C-5'), 55.6 (p, PMB), 40.5 (t, C-19) 
Aglycon (-PMB) S11:
To a solution of aglycon S10 (3 mg, 2.9 µmol, 1.0 eq) in CH 2 Cl 2 (1.5 mL) were added phosphate buffer (0.3 mL) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (1 mg, 5.7 µmol, 2.0 eq) in CH 2 Cl 2 (0.7 mL) at room temperature. After stirring for 1.5 h the reaction was quenched by addition of a sat. aq. NaHCO 3 solution and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic extracts were dried over MgSO 4 and concentrated under reduced pressure. The residue was taken up in MeOH and H 2 O (1:1) and purified by RP-HPLC (MeOH:H 2 O, gradient eluation). Compound S11 (3 mg, 2.8 µmol, 98%) was obtained as a colorless oil. 2H, Bz), 4H, Bz), 7.70 (s, 1H, 2H, Bz), 2H, Bz), 1H, Bz), 7.44 (d, J = 7.9 Hz, 1H, 2H, Bz), 7.16 (d, J = 7.9 Hz, 1H, 6.33 (d, J = 15.6 Hz, 1H, 6.24 (dd, J = 15.6, 6.3 Hz, 1H, 1H, , 5.45 (pdd, J = 4.6, 1.2 Hz, 1H, H-4'), 5.35 (ps, 1H, H-2'), 5.15 (ps, 1H, H-1'), 4.74 (dd, J = 11.7, 4.6 Hz, 1H, H-5'), 4.63 (dd, J = 11.7, 4.6 Hz, 1H, H-5''), 4.57 (dd, J = 9.2, 4.6 Hz, 1H, H-3'), 4. 2H, 1H, 2H, 2.97 (dd, J = 16.6, 3.9 Hz, 1H, , 2.92 (dd, J = 16.6, 10.6 Hz, 1H, H-17'), 2.57 (dd, J = 13.5, 6.3 Hz, 1H, H-24), 2.36-2.31 (m, 1H, H-24'), 2.31 (s, 3H, Ac), 2.14-2.09 (m 1H, H-19), 2.03- -1 ), 167.6 (q, Bz), 167.1 (q, Bz), 166.5 (q, Bz), 165.1 (q, C-16), 150.0 (q, C-3), 140.6 (q, C-14), 139.0 (q, C-7), 137.8 (t, C-5), 134.8 (t, C-12), 134.4 (t, C-15), 130.9 (6x t, Bz), 130.6 (4x t, Bz), 129.9 (2x t, Bz), 129.8 (2x t, Bz), 129.6 (4x t, Bz), 127.1 (q, C-2), 126.1 (t, C-6), 121.8 (t, C-13), 118.6 (q, C-4), 107.7 (t, C-1'), 83.4 (t, C-2'), 82.9 (t, C-3'), 79.2 (t, C-4'), 79.1 (t, C-18), 76.2 (t, C-9), 74.9 (t, C-20), 71.4 (t, C-11), 64.9 (s, C-5'), 44.4 (t, C-19), 40.2 (s, C-10), 38.1 (s, C-24), 36.8 (t, C-25), 34.2 (s, C-17), 30.5 (s, C-26), 30.4 (s, C-8), 27.8 (s, C-21), 21.0 (2x p, Ac), 19.4 (t, C-28), 11.9 (p, C-23), 11.0 (p, C-22), 10.5 (p, C-27) 
Noricumazole B (1b):
A solution of aglycon S11 (2 mg, 1.5 µmol, 1.0 eq) in MeOH/THF/H 2 O/Et 3 N (1.4 mL, 6:5:1:2) was stirred at 55 °C. After stirring for 2 d the solvent of the reaction mixture was removed and the residue directly taken up in MeOH and H 2 O (1:1) and purified by RP-HPLC (MeOH:H 2 O, gradient eluation). Noricumazole B (1b) (1 mg, 1.4 µmol, 98%) was obtained as a colorless oil. 
